Stocks and Investing
Stocks and Investing
Mon, September 25, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Ami Fadia Reiterated (AVDL) at Strong Buy and Held Target at $18 on, Sep 25th, 2023
Ami Fadia of Needham, Reiterated "Avadel Pharmaceuticals plc" (AVDL) at Strong Buy and Held Target at $18 on, Sep 25th, 2023.
Ami has made no other calls on AVDL in the last 4 months.
There are 3 other peers that have a rating on AVDL. Out of the 3 peers that are also analyzing AVDL, 0 agree with Ami's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Ami
- David Amsellem of "Piper Sandler" Maintained at Buy with Increased Target to $18 on, Thursday, August 10th, 2023
- Oren Livnat of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $21 on, Thursday, August 10th, 2023
- Francois Brisebois of "Oppenheimer" Maintained at Buy with Increased Target to $25 on, Friday, June 30th, 2023
Contributing Sources